Literature DB >> 30615229

Contrast-induced nephropathy is associated with new-onset atrial fibrillation in acute coronary syndrome after cardiac catheterization: Systemic review and meta-analysis.

Narut Prasitlumkum1, Chanavuth Kanitsoraphan1,2, Veraprapas Kittipibul3, Kittika Poonsombudlert1, Nath Limpruttidham1, Pattara Rattanawong1,4, Pakawat Chongsathidkiet5.   

Abstract

INTRODUCTION: Contrast-induced nephropathy (CIN) is associated with increased cardiovascular morbidity and mortality in patients with acute coronary syndrome (ACS). Recent studies suggest that CIN is associated with new-onset atrial fibrillation (AF) in patients with acute coronary syndrome (ACS) who underwent catheterization. However, a systematic review and meta-analysis of the literature have not been done. We assessed the association between CIN in patients with ACS and new-onset AF by a systematic review of the literature and a meta-analysis. HYPOTHESIS: CIN is associated with new-onset AF in patients with ACS.
METHODS: We comprehensively searched the databases of MEDLINE and EMBASE from inception to April 2018. Included studies were published cohort studies that compared new-onset AF after cardiac catheterization in ACS patient with CIN versus without CIN. Data from each study were combined using the random effects, generic inverse variance method of DerSimonian and Laird to calculate risk ratios and 95% confidence intervals.
RESULTS: Five studies from December 2009 to February 2018 were included in this meta-analysis involving 5,640 subjects with ACS (1,102 with CIN and 4,538 without CIN). Contrast-induced nephropathy significantly correlates with new-onset AF after cardiac catheterization (pooled risk ratio = 2.84, 95% confidence interval: 1.66-4.87, p < 0.001, I2  = 58%)
CONCLUSIONS: Contrast-induced nephropathy is associated with new-onset AF threefold among patients with ACS after cardiac catheterization. Our study warranted further study to establish the causality between CIN and new-onset AF.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute coronary syndrome; atrial fibrillation; contrast-induced nephropathy

Mesh:

Substances:

Year:  2019        PMID: 30615229      PMCID: PMC6931742          DOI: 10.1111/anec.12625

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  34 in total

1.  Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.

Authors:  J A Sterne; M Egger
Journal:  J Clin Epidemiol       Date:  2001-10       Impact factor: 6.437

2.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

Review 3.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

4.  Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation.

Authors:  Darar Al Khdair; Lamia Alshengeiti; Basem Elbarouni; Raymond T Yan; Francois R Grondin; Frederick A Spencer; Sven Pallie; David Brieger; Kim A Eagle; Iqwal Mangat; Sheldon Singh; Shaun G Goodman; Andrew T Yan
Journal:  Can J Cardiol       Date:  2012-03-21       Impact factor: 5.223

Review 5.  Atrial fibrillation pathophysiology: implications for management.

Authors:  Yu-ki Iwasaki; Kunihiro Nishida; Takeshi Kato; Stanley Nattel
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

6.  Contrast-induced nephropathy is associated with new-onset atrial fibrillation in acute coronary syndrome after cardiac catheterization: Systemic review and meta-analysis.

Authors:  Narut Prasitlumkum; Chanavuth Kanitsoraphan; Veraprapas Kittipibul; Kittika Poonsombudlert; Nath Limpruttidham; Pattara Rattanawong; Pakawat Chongsathidkiet
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-01-07       Impact factor: 1.468

7.  Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.

Authors:  Linda Fried; Cam Solomon; Michael Shlipak; Stephen Seliger; Catherine Stehman-Breen; Anthony J Bleyer; Paolo Chaves; Curt Furberg; Lewis Kuller; Anne Newman
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

8.  Prognostic impact of types of atrial fibrillation in acute coronary syndromes.

Authors:  Dennis H Lau; Luan T Huynh; Derek P Chew; Carolyn M Astley; Ashish Soman; Prashanthan Sanders
Journal:  Am J Cardiol       Date:  2009-09-25       Impact factor: 2.778

9.  Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.

Authors:  Uwe Zeymer; Lieven Annemans; Nicolas Danchin; Stuart Pocock; Simon Newsome; Frans Van de Werf; Jesús Medina; Héctor Bueno
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2018-04-03

Review 10.  Intersection of cardiovascular disease and kidney disease: atrial fibrillation.

Authors:  Nisha Bansal; Chi-yuan Hsu; Alan S Go
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

View more
  1 in total

1.  Contrast-induced nephropathy is associated with new-onset atrial fibrillation in acute coronary syndrome after cardiac catheterization: Systemic review and meta-analysis.

Authors:  Narut Prasitlumkum; Chanavuth Kanitsoraphan; Veraprapas Kittipibul; Kittika Poonsombudlert; Nath Limpruttidham; Pattara Rattanawong; Pakawat Chongsathidkiet
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-01-07       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.